Repetitive dosing with valproate sodium is safe, well tolerated, and possibly effective for managing headache in patients with chronic migraine.
In patients with episodic migraines, the occurrence of a migraine headache does not consistently impact nighttime sleep.
Compared to the general population, patients with newly diagnosed MS/CIS are more likely to have impaired cognitive function.
There was no significant effect of β2-agonists on the development of Parkinson disease in patients with COPD.
A substantial percentage of Medicare beneficiaries with sleep disorders (most commonly insomnia and obstructive sleep apnea) undergo evaluations by sleep specialists.
Predictors of all-cause hospitalizations in patients with MS included increased age, presence of a comorbidity, and having a history of hospital admissions.
Researchers examined how the associations of life event stress with impulsivity, anxiety, and depressed mood change in the presence of sleep disturbance.
The presence of P-tau181 may aid in the diagnosis and identification of prognostic outcomes in Alzheimer disease.
Researchers determined the risk for Guillain-Barré Syndrome following seasonal influenza vaccination in a real-world study.
The presence of migraine and increasing headache pain intensity are associated with higher rates of anxiety, depression, inflammation, and sleep conditions, among other disorders.
